These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23251706)

  • 1. Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils.
    Woodman ME; Worth RG; Wooten RM
    PLoS One; 2012; 7(12):e52276. PubMed ID: 23251706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophages.
    Mulye M; Bechill MP; Grose W; Ferreira VP; Lafontaine ER; Wooten RM
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e2988. PubMed ID: 25144195
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Muangsombut V; Withatanung P; Srinon V; Chantratita N; Stevens MP; Blackwell JM; Korbsrisate S
    Front Cell Infect Microbiol; 2017; 7():350. PubMed ID: 28848712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil extracellular traps exhibit antibacterial activity against burkholderia pseudomallei and are influenced by bacterial and host factors.
    Riyapa D; Buddhisa S; Korbsrisate S; Cuccui J; Wren BW; Stevens MP; Ato M; Lertmemongkolchai G
    Infect Immun; 2012 Nov; 80(11):3921-9. PubMed ID: 22927051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition.
    Reckseidler-Zenteno SL; DeVinney R; Woods DE
    Infect Immun; 2005 Feb; 73(2):1106-15. PubMed ID: 15664954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.
    Dando SJ; Ipe DS; Batzloff M; Sullivan MJ; Crossman DK; Crowley M; Strong E; Kyan S; Leclercq SY; Ekberg JAK; St John J; Beacham IR; Ulett GC
    Infect Immun; 2016 Jul; 84(7):1941-1956. PubMed ID: 27091931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living dangerously: Burkholderia pseudomallei modulates phagocyte cell death to survive.
    Krakauer T
    Med Hypotheses; 2018 Dec; 121():64-69. PubMed ID: 30396496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression profiles of lung epithelial cells exposed to Burkholderia pseudomallei and Burkholderia thailandensis during the initial phase of infection.
    Wongprompitak P; Sirisinha S; Chaiyaroj SC
    Asian Pac J Allergy Immunol; 2009 Mar; 27(1):59-70. PubMed ID: 19548631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes.
    Egan AM; Gordon DL
    Infect Immun; 1996 Dec; 64(12):4952-9. PubMed ID: 8945532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis.
    Warawa JM; Long D; Rosenke R; Gardner D; Gherardini FC
    Infect Immun; 2009 Dec; 77(12):5252-61. PubMed ID: 19752033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis.
    Wiersinga WJ; Kager LM; Hovius JW; van der Windt GJ; de Vos AF; Meijers JC; Roelofs JJ; Dondorp A; Levi M; Day NP; Peacock SJ; van der Poll T
    J Immunol; 2010 Mar; 184(6):3079-86. PubMed ID: 20142364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation in pyroptosis induction by Burkholderia pseudomallei and Burkholderia thailandensis in primary human monocytes, a possible cause of sepsis in acute melioidosis patients.
    Khongpraphan S; Ekchariyawat P; Sanongkiet S; Luangjindarat C; Sirisinha S; Ponpuak M; Midoeng P; Pudla M; Utaisincharoen P
    PLoS Negl Trop Dis; 2024 Jul; 18(7):e0012368. PubMed ID: 39042701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the type III capsular polysaccharide produced by Burkholderia pseudomallei.
    Reckseidler-Zenteno SL; Viteri DF; Moore R; Wong E; Tuanyok A; Woods DE
    J Med Microbiol; 2010 Dec; 59(Pt 12):1403-1414. PubMed ID: 20724509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico prediction of host-pathogen protein interactions in melioidosis pathogen Burkholderia pseudomallei and human reveals novel virulence factors and their targets.
    Loaiza CD; Duhan N; Lister M; Kaundal R
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32444871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis.
    Ngugi SA; Ventura VV; Qazi O; Harding SV; Kitto GB; Estes DM; Dell A; Titball RW; Atkins TP; Brown KA; Hitchen PG; Prior JL
    Vaccine; 2010 Nov; 28(47):7551-5. PubMed ID: 20837078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of host factors on neutrophil functions in response to Burkholderia pseudomallei in healthy Thai subjects.
    Saengmuang P; Kewcharoenwong C; Tippayawat P; Nithichanon A; Buddhisa S; Lertmemongkolchai G
    Jpn J Infect Dis; 2014; 67(6):436-40. PubMed ID: 25410558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malleilactone Is a Burkholderia pseudomallei Virulence Factor Regulated by Antibiotics and Quorum Sensing.
    Klaus JR; Deay J; Neuenswander B; Hursh W; Gao Z; Bouddhara T; Williams TD; Douglas J; Monize K; Martins P; Majerczyk C; Seyedsayamdost MR; Peterson BR; Rivera M; Chandler JR
    J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735757
    [No Abstract]   [Full Text] [Related]  

  • 18. Attenuation of a select agent-excluded Burkholderia pseudomallei capsule mutant in hamsters.
    Gutierrez MG; Warawa JM
    Acta Trop; 2016 May; 157():68-72. PubMed ID: 26836271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays.
    Welkos SL; Klimko CP; Kern SJ; Bearss JJ; Bozue JA; Bernhards RC; Trevino SR; Waag DM; Amemiya K; Worsham PL; Cote CK
    PLoS One; 2015; 10(4):e0124667. PubMed ID: 25909629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Immune Responses to Melioidosis and Cross-Reactivity to Low-Virulence Burkholderia Species, Thailand
    Rongkard P; Kronsteiner B; Hantrakun V; Jenjaroen K; Sumonwiriya M; Chaichana P; Chumseng S; Chantratita N; Wuthiekanun V; Fletcher HA; Teparrukkul P; Limmathurotsakul D; Day NPJ; Dunachie SJ
    Emerg Infect Dis; 2020 Mar; 26(3):463-471. PubMed ID: 32091359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.